Document is current
Any future updates will be listed below
-
Authors
Fonseca, Francina https://orcid.org/0000-0002-0779-6545
Robles-Martínez, María https://orcid.org/0000-0003-0324-8354
Tirado-Muñoz, Judit
Alías-Ferri, María
Mestre-Pintó, Joan-Ignasi https://orcid.org/0000-0003-0387-9375
Coratu, Ana Maria
Torrens, Marta https://orcid.org/0000-0001-6222-4761
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (P2018/030)
RED DE TRASTORNOS ADICTIVOS (RD16/0017/0010)
Suport de Grups de Recerca AGAUR-Gencat (2017 SGR 530)
- License Information
-
More Information
Article History
Accepted: 8 January 2021
First Online: 16 February 2021
Compliance with Ethical Standards
:
: FF has received during the last 3 years of travel grants from Lundbeck, Otsuka, Indivior, Pfizer, Gilead, and Servier, and she has received grant/research support from Indivior and Servier. MR has been a consultant/advisor and/or speaker for Lundbeck and Servier. MT has been a consultant/advisor and/or speaker for Gilead Sciences, Merck Sharp & Dohme Corp, Indivior, Mundipharma Pharmaceutics, Servier Adamed, Lundbeck, and Rovi.The authors declare no conflict of interest, and the funders had no role in the design of the study, data collection, analyses, and interpretation, in the writing of the manuscript, or in the decision to publish the results.
: Not applicable.
